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Abstract
Peripheral neuropathy is associated with an increase in intraneural pressure, and hence ultrasound elastography seems 
to be an ideal method to detect early stages of this condition based on changes in the affected nerve stiffness. The aim 
of this systematic review was to analyse the applicability of strain elastography (SE) and shear wave elastography (SWE) 
in the evaluation of peripheral nerves in patients with neuropathy of various aetiologies. Published evidence shows 
clearly that ultrasound elastography can accurately diagnose many types of peripheral neuropathies (carpal tunnel 
syndrome and other entrapment neuropathies, diabetic peripheral neuropathy and peripheral neuropathy associated 
with other systemic diseases), sometimes at the stages at which the condition is still asymptomatic. However, it is still 
unclear whether elastographic changes within the nerves precede functional anomalies detectable on nerve conduction 
studies. Also, relatively little is known about the relationship between the stiffness of peripheral nerves and the severity 
of peripheral neuropathy and its underlying condition. Based on the reproducibility data, SWE seems to be superior to 
SE. Nevertheless, the sources of heterogeneity in the peripheral nerve stiffness in healthy persons need to be identified, 
and the sets of reference values for specific peripheral nerves need to be determined. Finally, the potential confounding 
effect of hardening artefacts, such as bones, on the stiffness of peripheral nerves needs to be verified. After addressing 
all these issues, elastographic evaluation of peripheral nerve stiffness might become a reliable, easily accessible, and 
convenient diagnostic test performed routinely in patients with various peripheral neuropathies.
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Introduction
The term ‘peripheral neuropathy’ refers to a condition af-
fecting at least one peripheral nerve and contributing to 
impairment of its motor, sensory, and/or autonomic func-
tion. Common causes of neuropathy include systemic dis-
eases, nerve entrapment and/or ischaemia, inflammation 
(neuritis), traumatic injuries, viral infections, vitamin de-
ficiencies, and some medications. In most cases, neuropa-
thy is associated with an increase in intraneural pressure, 
resultant nerve oedema, compression of supplying blood 
vessels (vasa nervorum), and ischaemia. If prolonged, this 
will eventually lead to demyelination, axonal atrophy with 
secondary fibrosis, and functional deterioration of the 
nerve [1]. 
Because typically there is a lag phase between the onset 
of nerve degeneration and clinically evident dysfunction, 
diagnostic tests capable of detecting peripheral neuropathy 
at subclinical stages are of utmost importance. Depend-
ing on its location, function of the affected nerve can be 
controlled by nerve conduction studies (NCS), and mag-
netic resonance imaging (MRI) was shown to visualise 
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some early, preclinical alterations in peripheral nerve mor-
phology. However, these tests are expensive, not widely 
available, and inconvenient; furthermore, they are either 
invasive (NCS) or require administration of contrast agent 
(MRI), and their sensitivity and specificity are far from op-
timum [2-5].
Considering its lack of invasiveness, better availabili-
ty, and lower cost, conventional grey-scale ultrasound has 
been increasingly used as an accessory diagnostic test in 
patients with suspected peripheral neuropathies. Using 
conventional ultrasound, one can detect morphological 
changes in the affected peripheral nerve and quantify its 
cross-sectional area (CSA) [6,7]. However, as shown in 
this review, grey-scale ultrasound also has some limita-
tions in the evaluation of peripheral nerves. These draw-
backs can be overcome with ultrasound elastography, 
a relatively new diagnostic modality introduced in the 
1990s. Elastography is an ultrasound technique to evalu-
ate biological tissue stiffness [8]. The two most common-
ly used elastographic techniques are strain elastography 
(SE) and shear wave elastography (SWE). The former, 
older one is based on operator-induced compression with 
a transducer to evaluate tissue displacement and hence 
its elasticity/stiffness. The result is presented on a qual-
itative colour scale, with elastic, intermediate, and stiff 
tissues marked in red, green, and blue, respectively, or 
semi-quantitatively, as a strain/elasticity ratio between 
structures. In more recently introduced SWE, the velocity 
of a transducer-generated shear wave is measured across 
the tissue of interest and expressed as a quantitative pa-
rameter, in either kilopascals (kPa, as Young modulus) or 
metres per second (m/s) (Figures 1 and 2) [9].
Considering the previously mentioned pathophysiolo-
gy of peripheral neuropathy with an increase in intraneu-
ral pressure and oedema, ultrasound elastography seems to 
be an ideal method to detect early stages of this condition 
based on changes in the affected nerve stiffness. Therefore, 
the aim of this systematic review was to analyse the ap-
plicability of SE and SWE in the evaluation of peripheral 
nerves in patients with neuropathy of various aetiologies.
Material and methods
A systematic search of the PubMed, Scopus, and Google 
Scholar was carried out. All published studies that ana-
lysed the applicability of ultrasound elastography, whether 
SE or SWE, in the evaluation of peripheral nerves and 
used the terms ‘elastography’ OR ‘ultrasound elastogra-
phy’ OR ‘strain elastography’ OR ‘shear wave elastogra-
phy’ AND ‘neuropathy’ OR ‘peripheral neuropathy’ OR 
‘diabetic neuropathy’ OR ‘neuritis’ were identified and 
reviewed. The search limits were defined as ‘English’ (lan-
guage), and ‘the beginning of a given database through 
to 31 August 2019’ (publication date). To be eligible for 
the systematic review, identified papers needed to com-
pare the results of elastographic examination of peripheral 
nerves in patients with neuropathies of various origin and 
healthy controls. To provide a better insight into the appli-
cability of ultrasound elastography in specific conditions, 
each chapter of this paper includes also information about 
a specific aetiology of peripheral neuropathy, other rou-
tinely used tests, and limitations thereof.
All records were identified from searches of the elec-
tronic databases, and duplicates were removed. Then, two 
Figure 1. Shear wave elastography image of median nerve within the carpal tunnel in a 30-year-old man with no abnormalities in nerve conduction studies
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researchers (JZ and KZ) independently screened the titles 
and abstracts to identify the potentially eligible studies. 
Finally, studies that were potentially eligible were select-
ed for full-text review. Any disagreement was resolved 
by mutual consent after discussion. The characteristics 
recorded for each study included authors’ names, publi-
cation year, country of origin, publication year, number 
of patients and controls, elastographic method used, out-
come measures along with their values, and whenever 
available, parameters of diagnostic accuracy and repro-
ducibility measures.
A total of 14 studies satisfying the criteria of this re-
view were identified (Table 1). Published data on the ap-
plicability of ultrasound elastography to the evaluation of 
peripheral neuropathies are presented separately for six 
different indications. Furthermore, potential limitations 
of this diagnostic modality are discussed along with di-
rections of future research.
Carpal tunnel syndrome
Carpal tunnel syndrome (CTS) is the most common com-
pression neuropathy of the upper extremities, resulting 
from entrapment of the median nerve in the carpal tun-
nel at the wrist. Currently, the gold standard in the eval-
uation of CTS is NCS, but its invasiveness and relatively 
high false-negative rate (up to 30%) have led to research 
on other less invasive and more convenient diagnostic 
options [2,3,10]. One such method is ultrasound exam-
ination with the assessment of median nerve morpholo-
gy and function and the determination of CSA at various 
levels of the carpal tunnel, mostly at the inlet, mid-tunnel, 
and outlet [11]. While multiple studies demonstrated 
that the ultrasonographically determined CSA of the me-
dian nerve was markedly higher in CTS patients than in 
healthy controls, conventional ultrasound was also shown 
to suffer from a lack of standardisation. As a result, the 
range of proposed cut-off values for CSA measurements 
is quite wide: from 6.5 mm2 to 15 mm2. This contributed 
to substantial heterogeneity of sensitivity (57-97.9%) and 
specificity (51-100%) of ultrasonographically determined 
CSA in the diagnostics of CTS [7,12-18]. To reduce the 
discrepancies in the CSA measurements, comparison of 
the cross-sectional area of the median nerve within the 
carpal tunnel to an unaffected site, such as the forearm, 
has been proposed, and the swelling ratio has been sug-
gested as a promising method, but the accuracy of this 
method is still unclear [19,20].
The results of a few published studies suggest that the 
drawbacks of conventional ultrasonography can be over-
come with ultrasound elastography. The studies, involving 
either SE or SWE, demonstrated unequivocally that pe-
ripheral nerves in patients with CTS become stiffer than 
in healthy persons. In an SE-based study carried out by 
Orman et al. [21] in 41 CTS patients (74 wrists) and 24 
asymptomatic controls (45 wrists), mean tissue strain in 
the former group was significantly lower than in the lat-
ter (0.094 ± 0.045 vs. 0.145 ± 0.068), which implied that 
the affected median nerves were stiffer than the normal 
ones. In the same study, a cut-off strain ratio of 0.0635 was 
shown to be the most sensitive (sensitivity 88%, specificity 
45%) and a cut-off of 0.19 the most specific (sensitivity 
65%, specificity 88%) in distinguishing between persons 
with CTS and without [21]. In another SE study conducted 
Figure 2. Shear wave elastography image of ulnar nerve proximally to Guyon’s canal in a 40-year-old woman with ulnar neuropathy confirmed in nerve 
conduction studies
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by Ghajarzadeh et al. [22], the ratio of total red pixels to 
total pixels in elastographic images of the median nerve 
turned out to be significantly higher in healthy controls 
(n = 21, 44 nerves) than in individuals with CTS (n = 31, 
60 nerves), which also suggests that the affected nerves are 
less elastic than the normal ones. 
The abovementioned findings are consistent with the 
results of an SWE-based study carried out by Kantarci et 
al. [23] in 37 patients (60 wrists) with a definitive diag-
nosis of CTS and 18 healthy controls (36 wrists). Medi-
an nerve stiffness at the carpal tunnel inlet in the CTS 
group turned out to be significantly higher than in the 
controls (66.7 kPa vs. 32.0 kPa), and a 40.4-kPa cut-off 
value on SWE provided 93.3% sensitivity, 88.9% speci-
ficity, 93.3% PPV, 88.9% NPV, and 91.7% accuracy in the 
diagnosis of carpal tunnel syndrome [23]. Similar findings 
were also reported by Zhang et al. [24]. Those authors used 
SWE, but instead of the Young modulus values expressed in 
kPa, they measured shear wave velocity (SWV; m/s) at 
the carpal tunnel inlet using Virtual Touch tissue imag-
ing quantification. Median nerve SWV in the CTS group 
(n = 49, 72 wrists) was significantly higher than in 
the healthy controls (n = 23, 46 wrists) (3.857 m/s vs. 
2.542 m/s) [24]. Finally, Paluch et al. [25] used SWE to 
determine the median nerve stiffness in 87 wrists with 
confirmed CTS and 34 without. Similar to the studies 
mentioned above, patients with CTS presented with sig-
nificantly higher median stiffness of the median nerve 
at the wrist than the controls (100 kPa vs. 42 kPa), with 
a cut-off value of 79 kPa providing 96.6% sensitivity, 100% 
Table 1. Published studies analysing the applicability of ultrasound elastography to the evaluation of peripheral neuropathies
Authors Indication Examined
 nerve(s)
Elastographic 
method
Participants
Orman et al. [21] CTS Median nerve SE 41 patients with CTS (74 nerves)
24 controls (45 nerves)
Ghajarzadeh et al. [22] CTS Median nerve SE 31 patients with CTS (60 nerves)
21 controls (44 nerves)
Tatar et al. [26] CTS Median nerve SE 19 patients with CTS (35 nerves)
18 controls (36 nerves)
Kantarci et al. [23] CTS Median nerve SWE 37 patients with CTS (60 nerves)
18 controls (36 nerves)
Zhang et al. [24] CTS Median nerve SWE 49 patients with CTS (72 nerves)
23 controls (46 nerves)
Paluch et al. [25] CTS Median nerve SWE 87 nerves with CTS
34 nerves without CTS
Paluch et al. [29] UTS Ulnar nerve SWE 46 patients with UTS
39 controls
Paluch et al. [31] UNE Ulnar nerve SWE 34 patients with UTS
38 controls
Ishibashi et al. [41] DPN Tibial nerve SE 198 patients with type 2 diabetes mellitus
29 non-diabetic controls
Dikici et al. [40] DPN Tibial nerve SWE 20 patients with type 2 diabetes mellitus and DPN
20 patients with type 2 diabetes mellitus without DPN
20 non-diabetic controls
He et al. [43] DPN Tibial nerve
Median nerve
SWE 40 patients with type 2 diabetes mellitus and DPN
40 patients with type 2 diabetes mellitus without DPN
40 non-diabetic controls
Yagci et al. [48] CTS in SSc Median nerve SE 24 patients with SSc without CTS (47 nerves)
27 patients with SSc and CTS (53 nerves)
19 controls (38 nerves)
Inal et al. [53] Optic neuropathy 
in BD
Optic nerve SE
SWE
23 patients with BD (46 nerves)
27 controls (54 nerves)
Inal et al. [62] Optic neuritis 
in MS
Optic nerve SE
SWE
54 patients with MS (107 nerves)
59 controls (118 nerves)
BD – Behçet’s disease, CTS – carpal tunnel syndrome, DPN – diabetic peripheral neuropathy, MS – multiple sclerosis, SE – strain elastography, SSc – systemic sclerosis, SWE – shear wave elas-
tography, UTS – ulnar tunnel syndrome, UNE – ulnar neuropathy of the elbow
 Elastography in the evaluation of peripheral neuropathies
e585© Pol J Radiol 2019; 84: e581-e591
specificity and positive predictive value (PPV), and 91.9% 
negative predictive value (NPV) in distinguishing between 
the two groups. However, considering the substantial var-
iance in the results of healthy controls (range 24-76 kPa), 
the authors proposed to diagnose CTS based on the wrist-
to-forearm ratio of median nerve stiffness, rather than on 
the basis of the absolute stiffness of the nerve. Median val-
ues of the two stiffness ratios obtained by dividing median 
nerve stiffness at the level of the proximal carpal row and 
12 cm or 20 cm proximally on the forearm, respective-
ly, were significantly higher in CTS patients than in the 
controls (2.1 vs. 1.0, regardless of the location), and the 
cut-off values of 1.483 and 1.508, respectively, provided 
the same, excellent accuracy in distinguishing between 
patients with CTS and without (97.7% sensitivity, 100% 
specificity and PPV, 94.4% NPV) [25].
While the abovementioned data demonstrate clearly 
that ultrasound elastography, especially SWE, is suitable 
for the detection of CTS, less obvious is the link between 
the median nerve stiffness and severity of the disease. In 
the SE study conducted by Ghajarzadeh et al. [22], mean 
total blue pixel number and total blue pixel to total pixel 
index values increased significantly with advancing CTS 
severity, but decreased in cases with the most severe form 
of the disease. According to the authors of this study, this 
could be associated with axonal loss in more advanced cases 
[22]. In another SE-based study, Tatar et al. [26] compared 
median nerve strain ratio at the wrist in 18 healthy volun-
teers (36 wrists) and 19 patients with mild (15 wrists) and 
moderate to severe CTS (20 wrists). While mean strain 
ratios in both CTS groups were significantly higher than 
in the controls (3.15 ± 0.09 in mild CTS and 3.04 ± 0.96 
in moderate-severe CTS vs. 1.85 ± 0.65 in the controls), 
the strain ratio did not change significantly depending 
on CTS severity [26]. Similarly, Paluch et al. [25] claimed 
on the lack of statistically significant correlation between 
the median nerve stiffness determined by means of SWE 
and CTS severity, although they did not provide the ex-
act numbers supporting this observation. The results of 
the two studies mentioned above remain in opposition to 
the findings reported by Kantarci et al. [23], according to 
whom median nerve stiffness in patients with severe or 
extremely severe CTS turned out to be significantly higher 
than in those with mild or moderate disease (101.4 kPa 
vs. 55.1 kPa).
To summarise, the results of available studies suggest 
that patients with even mild CTS can be accurately identi-
fied using ultrasound elastography, preferably SWE. How-
ever, this review of literature demonstrated also substan-
tial heterogeneity of median nerve stiffness in both CTS 
patients and healthy controls. This implies that aside from 
the neuropathic process, the stiffness of the median nerve 
can also be influenced by other factors. Indeed, some ex-
perimental data suggest that the results of SWE might be 
modulated by carpal tunnel pressure. Using the Achilles 
tendon model, Wang et al. [27] demonstrated that both 
the absolute SWV and the speed difference between the 
inside and outside tunnel increased linearly with the tun-
nel pressure. Furthermore, increased carpal tunnel pres-
sure in CTS was shown to affect blood circulation within 
the median nerve, and long-term oedema of the nerve is 
known to trigger fibroblast invasion, resultant accumu-
lation of scar tissue inside the nerve, and an increase in 
its stiffness [28]. Future studies should verify if and how 
these experimental data translate onto real-life clinical 
practice.
Other entrapment neuropathies
The usefulness of ultrasound elastography in the evalua-
tion of peripheral nerve stiffness in patients with CTS was 
recently confirmed in two studies analysing other types of 
entrapment neuropathies.
Paluch et al. [29] analysed the applicability of SWE 
in ulnar tunnel syndrome (UTS), a compressive neurop-
athy of the ulnar nerve at the level of Guyon’s canal [30]. 
The study included 46 patients with electromyographical-
ly confirmed UTS and 39 healthy controls. Mean SWE at 
Guyon’s canal turned out to be significantly higher in UTS 
patients than in the controls (99.41 kPa vs. 49.08 kPa), and 
the stiffness of 80 kPa or higher, as well as the ratios of ul-
nar nerve stiffness at Guyon’s canal to its stiffness at distal 
or proximal forearm equal to 1.5 provided an excellent, 
100% sensitivity, specificity, PPV, and NPV in distinguish-
ing between patients with UTS and without [29].
In another study conducted by the same group [31], 
the SWE stiffness of the ulnar nerve at the cubital tunnel 
in 34 patients with ulnar neuropathy of the elbow (UNE), 
the second most common entrapment neuropathy caused 
by compression of the ulnar nerve at the elbow or its di-
rect proximity [32], was compared with the stiffness of 
this nerve in 38 healthy controls. Mean SWE of the ulnar 
nerve in the cubital tunnel was significantly higher in the 
patient group than in the controls (96.38 ± 9.62 kPa vs. 
33.08 ± 10.13 kPa), and so were the median ratios of the 
nerve stiffness in the cubital tunnel to its stiffness at the 
distal arm (2.8 vs. 1.0) and mid-arm (2.7 vs. 1.0). A cut-off 
value of ulnar nerve stiffness of 61 kPa, as well as the ulnar 
nerve stiffness ratios at distal arm and mid-arm of 1.68 
and 1.75, respectively, provided an excellent 100% sensi-
tivity, specificity, PPV, and NPV in distinguishing between 
patients with UNE and without [31].
Diabetic peripheral neuropathy
Similar to CTS and other entrapment neuropathies, NCS 
can detect diabetic peripheral neuropathy (DPN) and are 
considered a gold standard in this indication. However, as 
already mentioned above, they are time-consuming and 
invasive; furthermore, the results of NCS in DPN were 
shown to be biased by skin temperature and humidity 
[33]. Finally, the latent phase of DPN development is long, 
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up to 4-7 years, and hence we need a diagnostic method 
capable of predicting DPN before functional anomalies 
emerge on NCS.
Technological progress has opened perspectives for 
the application of conventional grey-scale ultrasound in 
the evaluation of patients with suspected DPN. Like in 
CTS, ultrasound can provide information about the CSA, 
echogenicity, and inner structure of nerves affected by 
DPN. However, the results of previous studies analysing 
the applicability of grey-scale ultrasound for the measu-
rement of CSA in DPN are inconclusive. While some of 
those studies demonstrated that DPN was associated with 
an increase in CSA [34-36], others did not find differenc-
es in the cross-sectional areas of affected and unaffected 
nerves [37], or even showed a decrease in the dimensions 
of the affected nerves [38,39]. Furthermore, a few authors 
observed that the CSA of peripheral nerves varied de-
pending on the type of the diabetes and its severity. Dikici 
et al. [40] reported that the CSA of anterior tibial nerve 
in type 2 diabetic patients with symptomatic neuropathy 
was different than in healthy controls but not in diabetic 
patients without the evidence of neuropathy. According 
to Ishibashi et al. [41], the CSA of tibial nerve in patients 
with type 2 diabetes mellitus increased with the severity 
of neuropathy. Breiner et al. [42] demonstrated that type 1 
diabetes was associated with an increase in mean periph-
eral nerve thickness, but the CSA of the affected nerves 
was smaller than in patients with type 2 diabetes. Finally, 
in the study conducted by He et al. [43], CSA of the tibial 
nerve in patients with DPN was significantly higher than 
in diabetic patients without the neuropathy and healthy 
controls, whereas the CTS values for median nerve did 
not differ significantly between the study groups. Accord-
ing to the authors of this study, the lack of statistically 
significant between-group differences might be associated 
with the fact that CSA was determined at the mid-arm 
where the median nerve is unlikely to be compressed [43]. 
Regardless of the reason, published evidence shows clearly 
that the diagnosis of DPN solely on the basis of the CSA 
can be a subject of considerable bias.
The results of elastographic studies, whether with SE 
or SWE, are more straightforward. Ishibashi et al. [41] 
used SE to determine the elasticity of tibial nerves 3 cm 
proximal to the medial malleolus in 198 patients with type 
2 diabetes mellitus and 29 age- and sex-matched non-di-
abetic controls. The elasticity, expressed as the elasticity 
ratio, turned out to be significantly higher in healthy con-
trols (0.760 ± 0.0235) and to decrease significantly with 
the severity of diabetic peripheral neuropathy (0.655 ± 
0.0146 vs. 0.542 ± 0.0144 vs. 0.475 ± 0.0193 vs. 0.414 ± 
0.0176 for stages I to VI, respectively). The cut-off value 
of elasticity of the tibial nerve that suggested the presence 
of neuropathy was 0.558 and provided 86% sensitivity and 
62% specificity; these parameters of diagnostic accuracy 
were significantly higher than in the case of CSA deter-
mined by means of conventional ultrasound [41].
The results obtained with SE are consistent with more 
recent SWE findings. Dikici et al. [40] used SWE to de-
termine the stiffness of tibial nerves in patients with type 
2 diabetes mellitus complicated by diabetic peripheral 
neuropathy (n = 20), diabetic patients without neuropathy 
(n = 20), and non-diabetic controls (n = 20). The tibial 
nerve was examined 4 cm proximal to the medial malleolus. 
The nerve in patients with established neuropathy proved to 
be significantly stiffer than in both non-neuropathy diabetic 
patients and healthy controls (right tibial nerve: 79.5 ± 25.7 
kPa vs. 45.6 ± 16.2 kPa vs. 30.3 ± 7.6 kPa; left tibial nerve: 
77.0 ± 25.3 kPa vs. 36.2 ± 11.5 kPa vs. 31.3 ± 11.6 kPa); 
furthermore, a significant difference in the right but not 
left tibial nerve stiffness was found between the latter two 
groups. A cut-off value of 51.0 kPa provided 90% sensitivi-
ty and 85% specificity in the detection of diabetic peripher-
al neuropathy [40]. Finally, He et al. [43] determined SWE 
stiffness of tibial and median nerve in 40 patients with type 
2 diabetes and DPN, 40 diabetic patients without DPN, 
and 40 healthy controls. The tibial nerve was examined 
3 cm above the medial malleolus and the median nerve at 
the midpoint of the forearm. The study demonstrated that 
regardless of the body side, patients with DPN presented 
with significantly lower SWV in both tibial (left side: 3.67 
± 0.47 m/s vs. 3.70 ± 0.49 m/s vs. 4.48 ± 0.59 m/s; right side: 
3.64 ± 0.49 m/s vs. 3.71 ± 0.52 m/s vs. 4.63 ± 0.54 m/s) and 
median nerve (left side: 3.51 ± 0.57 m/s vs. 3.54 ± 0.60 
m/s vs. 4.41 ± 0.76 m/s, right side: 3.54 ± 0.52 m/s vs. 3.57 
± 0.55 m/s vs. 4.40 ± 0.62 m/s) than the other two groups. 
The optimal cut-off values for SWE of the tibial nerve and 
median nerve in the diagnosis of DPN were 4.11 m/s and 
4.06 m/s, respectively, with a good sensitivity (81.3% and 
80%, respectively) and specificity (88.7% and 85%, respec-
tively). Interestingly, while the CSA of both left and right 
tibial nerve was significantly higher in DPN patients, no 
statistically significant between-group differences were ob-
served in median nerve CSA [43].
In summary, published evidence suggests that ultra-
sound elastography, especially SWE, might find appli-
cation as a diagnostic test in DPN. In all of the studies 
mentioned above, patients with DPN presented with sig-
nificantly higher peripheral nerve stiffness than healthy 
controls. Furthermore, in two of these studies [40,43], in-
creased stiffness of the examined nerves was also observed 
in diabetic patients without clinical evidence of DPN, 
which implies that elastography could be not only a con-
firmatory but also a screening test for this complication. 
However, diagnostic accuracy of elastographic parame-
ters in the detection of DPN seems to be relatively low, 
no greater than 90%, and hence, unless standardised, this 
method does not seem suitable as a standalone diagnostic 
test. Furthermore, it needs to be stressed that DPN affects 
multiple nerves, and thus the fact that a given patient pre-
sents with normal stiffness of one of the most commonly 
examined nerves does not mean that the morphology of 
the others is not altered.
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Peripheral neuropathy in systemic sclerosis
In some forms of systemic sclerosis (SSc), an autoimmune 
condition of unknown aetiology associated with enhanced 
deposition of collagen in connective tissue, fibrotic lesions 
may develop in locations other than the skin [44]. Thick-
ening of connective tissue around or within a peripheral 
nerve may lead to neuropathy, a rare albeit serious com-
plication of SSc. According to literature, the most frequent 
forms of peripheral neuropathy in SSc are trigeminal neu-
ropathy, peripheral sensorimotor neuropathy, and CTS 
[45]. It is still unclear whether these conditions develop 
in a typical mechanism of compression neuropathy or are 
also associated with the deposition of collagen within the 
nerve. The aim of a few previous studies was to address 
this issue based on ultrasonographic and/or elastographic 
examination of the median nerve in patients who devel-
oped CTS secondarily to SSc.
The evidence from these studies suggests that CTS 
occurring concomitantly to SSc is also associated with 
ultra sonographically-detectable morphological alterations 
of the median nerve. Specifically, patients with SSc pre-
sented with larger CSA, higher transverse diameters, and 
higher flattening ratios of the median nerve than healthy 
controls [46] and had lower ratio of fascicular to non-fas-
cicular structures within the nerve [47]. These findings 
are consistent with the ultrasonographic observations of 
patients with CTS of other aetiology, suggesting that pe-
ripheral neuropathy in SSc might develop in a compres-
sion mechanism.
However, the results of a study analysing the stiffness 
of median nerve in SSc (to the best of our knowledge, 
the only one conducted to date) imply that systemic scle-
rosis might also affect the function of the median nerve 
directly. Yagci et al. [48] used SE to examine 24 patients 
(47 median nerves) with SSc but without any evidence 
of CTS from nerve conduction studies, 27 patients 
(53 nerves) with idiopathic CTS confirmed on NCS, and 
19 healthy volunteers (38 nerves). While SSc patients and 
healthy controls presented with significantly lower CSA 
of the median nerve than individuals with CTS, the stiff-
ness of the nerve, expressed as elastic ratios at pisiform 
and forearm levels was significantly higher in SSc than in 
other groups (pisiform level: 3.02 ± 2.56 in SSc group vs. 
2.19 ± 0.93 in CTS group vs. 1.63 ± 1.15 in the controls; 
forearm level: 3.21 ± 1.81 vs. 2.29 ± 1.39 vs. 1.77 ± 1.21, 
respectively). According to the authors of the study, the 
fact that median nerves in patients with SSc were stiffer 
than in persons with CTS suggests that also thickening 
of connective tissue within the nerve might play a role in 
the development of peripheral neuropathy secondary to 
systemic sclerosis [48].
Unfortunately, based on the results of this single study, 
we cannot conclude unequivocally that the aetiology of 
CTA (and perhaps also other peripheral neuropathies) 
in SSc is disease-specific or multifactorial, especially 
because, at the time of the elastographic evaluation, SSc 
patients participating in the study conducted by Yagci 
et al. [48] did not show any abnormalities in the results of 
NCS. Hence, a longitudinal elastographic study, prefera-
bly involving SWE, is needed to formulate any ultimate 
conclusions about the aetiology of peripheral neuropathy 
in SSc. Nevertheless, even based on the limited available 
evidence, ultrasound elastography seems to be a valuable 
diagnostic instrument in this indication.
Optic neuropathy in Behçet’s disease
Behçet’s disease (BD) is a chronic autoimmune disease 
with heterogeneous clinical manifestation, being a conse-
quence of multisystem vasculitis of unknown origin [49]. 
BD may also produce multiple ocular complications, such 
as relapsing, remitting panuveitis, retinal vasculitis, reti-
nitis, retinal haemorrhage, macular oedema, and retinal 
vascular occlusion and necrosis [50,51]. Optic neuropathy 
in BD may be a consequence of the occlusion of small 
supplying vessels and ascending inflammation spreading 
from the uveal tract [49,50,52]. In late stages, the neurop-
athy is associated with axonal degeneration and fibrosis 
[50,52]; these processes might contribute to greater stiff-
ness of the optic nerve, analogously to the other periphe-
ral neuropathies described above.
To the best of our knowledge, this hypothesis was ver-
ified in only one study. Inal et al. [53] examined 46 optic 
nerves from 23 patients with BD and 54 optic nerves from 
27 healthy volunteers using conventional ultrasound, SE, 
and SWE. The study demonstrated that mean thickness of 
the optic nerve in BD patients was significantly lower than 
in the controls (4.86 mm vs. 4.97 mm). Furthermore, the 
authors found a statistically significant difference in the SE 
elasticity patterns in BD patients and healthy volunteers. 
Most optic nerves in healthy controls represented type 3 
(intermediate tissue, green pixels, 51.8%) or type 2 (hard 
tissue, blue-green pixels, 40.7%) and rarely showed the 
characteristics of type 1 (hardest tissue, blue pixels, 7.5%). 
In contrast, the latter type (43.5%), as well as type 2 (52.2%), 
were the most abundant elasticity patterns in BD patients. 
Moreover, BD patients presented with significantly higher 
SWE stiffness of the optic nerve than the controls (32.1 ± 
13.9 kPa vs. 11.5 ± 5.6 kPa). A cut-off value of 16.5 kPa 
provided very good accuracy in distinguishing between 
patients with BD and without, with sensitivity and spec-
ificity of 87%, 85.1% PPV, and 88.7% NPV. The group of 
patients with BD included seven persons (14 eyes) with 
uveitis. Mean SWE stiffness in this group was not signifi-
cantly higher than in other patients with BD (36.4 kPa vs. 
30.95 kPa) [53].
Taken altogether, these findings imply that an increase 
in optic nerve stiffness can be detected at early stages of 
BD and might predict ocular complications associated 
with this condition. If these clinically attractive observa-
tions were confirmed in a larger longitudinal study, SWE 
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could play a key role in the secondary prevention of per-
manent loss of vision due to BD.
Optic neuropathy in multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory neuro-
degenerative disease affecting the central nervous system 
[54,55] and associated with demyelination and iron-related 
abnormalities [56,57]. While impaired vision, one of the 
most common symptoms of MS, may be associated with 
involvement of the visual system at any anatomical site, its 
best known pathomechanism is inflammatory demyelinat-
ing optic neuritis [58,59]. This condition can be detected 
with conventional and non-conventional MRI techniques, 
such as diffusion tensor imaging, diffusion-weighted imag-
ing, and magnetisation transfer imaging [60,61], but they 
are time consuming, costly, and less available.
In the search for an alternative diagnostic method, Inal 
et al. [62] examined 107 optic nerves from 54 MS patients 
(among them 27 nerves with previous optic neuritis diag-
nosed based on medical history and clinical findings) and 
118 optic nerves from 59 healthy controls, using SE and 
SWE. Based on the results of SE, optic nerves were clas-
sified into three elasticity types: type 1, the hardest (with 
predominance of blue pixels); type 2, hard (with predomi-
nance of blue/green pixels; and type 3, intermediate (with 
predominance of green pixels). The study demonstrated 
significant differences in the distribution of these elastic-
ity types in MS patients in healthy controls. While in all 
controls, optic nerves represented type (61.9%) or type 2 
(38.1%), the vast majority of MS patients (88%) presented 
with type 2 optic nerves, and type 3 was found in no more 
than 6.5% of the cases. Also, the SWE stiffness of the optic 
nerve differed significantly between the study groups, with 
significantly higher values found in MS patients than in the 
controls (33.87 ± 11.64 kPa vs. 10.381 ± 3.48 kPa). A cut-
off value of 18.3 kPa was shown to provide very high sensi-
tivity, specificity, PPV, and NPV (95.3%, 97.5%, 97.2%, and 
95.8%, respectively) in distinguishing between MS patients 
and healthy controls. Importantly, no significant differenc-
es in SWE stiffness were observed when optic nerves of MS 
patients were stratified into those with the history of previ-
ous neuritis and without (33.87, 11.6 vs. 33.88, 11.33) [62].
While these findings undoubtedly need to be verified 
in a larger series of patients, the evidence from this single 
study suggests that ultrasound elastography, whether SE or 
SWE, could be used to detect MS-related anomalies in the 
optic nerve. Considering the lack of statistically significant 
differences in the SWE stiffness of the optic nerve in pa-
tients with a history of neuritis and without, these anom-
alies might be detected even at early, asymptomatic stages.
Technical aspects to be addressed
While some of the studies reviewed above used SE to de-
termine the peripheral nerve stiffness, SWE seems to be 
more applicable in this indication. First, the result of SWE 
is 100% quantitative, unlike the qualitative or semi-quan-
titative outcome of SE. Second, SWE is less operator de-
pendent because the examination does not require con-
trolled compression of tissue with a transducer, hence 
eliminating a source of potential bias. These two factors 
contributed to very good or excellent reproducibility of 
SWE results in the evaluation of peripheral nerve stiffness. 
According to Kantarci et al. [23], the inter-observer agree-
ment rates in the measurement of median nerve stiffness 
in CTS patients and healthy controls were excellent: 0.848 
and 0.809, respectively. Even higher consistency of SWE 
measurements was reported by He et al. [43] in the evalu-
ation of median and tibial nerve stiffness in patients with 
DPN, diabetic patients without neuropathy, and healthy 
controls; the inter- and intra-observer agreement rates in 
this study were 0.958 and 0.960, respectively. According to 
Bortolotto et al. [9], the inter-observer agreement in the 
evaluation of median nerve stiffness in healthy volunteers 
was fair to moderate (intraclass correlation coefficients, 
ICC between 0.38 and 0.44, depending on the examined 
site), but it needs to be emphasised that the study involved 
one expert and one inexperienced operator, with six years 
and six months of ultrasound experience, respectively. 
Although the results presented in this review are 
without doubt promising, some issues still need to be ad-
dressed before ultrasound elastography can be routinely 
used in the evaluation of peripheral neuropathies. One of 
the key questions is the identification of normal values for 
peripheral nerve stiffness, because the evidence from most 
published studies suggests that even in healthy persons, 
the results of elastography can be quite heterogeneous. For 
example, mean median nerve stiffness at the wrist in CTS-
free controls included in the study conducted by Paluch 
et al. [25] was higher than in CTS-free volunteers exam-
ined by Kantarci et al. [23] (43.6 kPa vs. 32kPa, respec-
tively). Furthermore, the range of normal values in the 
former study was highly heterogeneous (24-76 kPa) and 
partially overlapped with those found in CTS patients 
(35-135 kPa) [25]. The same refers to the cut-off values 
distinguishing between the neuropathy patients and 
healthy controls, which differed substantially from study 
to study. For example, the cut-off value that distinguished 
between CTS patients and healthy persons in the study 
by Paluch et al. [25] was nearly twice as high as the one 
identified by Kantarci et al. [23] (79 kPa vs. 40.4 kPa).
Some authors made an attempt to identify the refer-
ence values for SWE peripheral nerve stiffness, but these 
relatively small studies produced quite inconclusive re-
sults. For example, Bedewi et al. [63] evaluated the SWE 
stiffness of C5-C7 nerve roots of the brachial plexus at 
the interscalene interval in 40 healthy persons, obtaining 
relatively low mean values: 16.9 ± 4.9 kPa for C5, 15.7 ± 
4.3 kPa for C6, and 16.0 ± 4.6 kPa for C7. The same group 
[64] made an attempt to determine the SWE stiffness of 
median nerve in 10 patients (20 nerves) with no history 
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of CTS or other neuropathies. Mean SWE stiffness at the 
wrist and 10 cm proximally was 20.78 ± 5.11 and 11.43 
± 6.30 [64], respectively. These values were considerably 
lower than the results for healthy controls in most SWE 
studies of the median nerve mentioned in this review. 
Moreover, they differed from the results obtained by Bor-
tolotto et al. [9] in 36 healthy volunteers with no present 
or past history of carpal tunnel syndrome, other forearm 
and wrist pathologies, and medical conditions possibly fa-
vouring CTS development. Mean values of median nerve 
stiffness in this group were 32.26 ± 18.6 kPa within the 
carpal tunnel, 22.20 ± 9.84 kPa at the tunnel inlet, and 
7.62 ± 7.38 kPa in the forearm [9].
As emphasised by Paluch et al. [65], the discrepancies in 
the results of previous studies of healthy controls might be 
explained by methodological differences (discussed in detail 
below) and/or the influence of some biological confound-
ers. Relationships between peripheral nerve stiffness and 
patient-related characteristics were analysed by only a few 
authors, and the results of these studies are inconclusive. In 
the study of Ishibashi et al. [41], the elasticity of tibial nerve 
in type 2 diabetic patients with DPN and healthy controls 
correlated inversely with age. However, Yagci et al. [48] 
found no significant correlations between the SWE stiffness 
of the optic nerve and age of either SSc patients or healthy 
controls. Similarly, no significant correlations between the 
optic nerve stiffness and age were found in patients with MS 
and healthy controls examined by Inal et al. [62].
Aside from the severity of peripheral neuropathy and 
its underlying condition (discussed in detail in previous 
chapters) and the potential biological confounders men-
tioned above, another source of variance in the results of 
elastographic studies can be methodological differences 
and some technological drawbacks. Available evidence 
suggests that the SWE stiffness of peripheral nerves can 
change depending on the plane on which the measure-
ments were taken [65]. This issue was addressed well in 
the study conducted by Aslan et al. [39], who examined 
median and posterior tibial nerve stiffness in 25 adoles-
cents with type 1 diabetes mellitus without DPN and 32 
healthy volunteers. The SWE measurements were taken 
by two observers on the transverse and longitudinal axes. 
Interobserver agreement for the shear modulus, elastic 
modulus, and SVW were lower on the transverse axis 
(0.210-0.633) than on the longitudinal axis (0.682-0.748). 
Based on those findings, the authors concluded that the 
reliability of the SWE measurements might be jeopardised 
by the imaging axis, unintentional compression on the 
transverse axis, and small microarchitectural differences 
through the nerve, and recommended longitudinal-axis 
SWE as more appropriate, proper, practical, and repro-
ducible for peripheral nerves [39].
Another technological aspect that needs to be ad-
dressed during the elastographic evaluation of peripheral 
nerves is the close proximity of bone surfaces that might 
act as hardening artefacts [9]. Such artefacts occur when 
the studied structure is near a hard plane (e.g. bone) that 
prevents homogeneous propagation of shear wave at depth 
and contributes to local stress inhomogeneity [66]. To the 
best of our knowledge, the impact of these artefacts on the 
SWE measurements of peripheral nerve stiffness has not 
been analysed thus far.
Conclusions
The evidence presented above shows clearly that ultra-
sound elastography can accurately diagnose many types 
of peripheral neuropathies, not infrequently at the stages 
at which the condition is still asymptomatic. However, 
we still do not know whether elastographic changes with-
in the nerves precede functional anomalies detectable on 
nerve conduction studies. Also, relatively little is known 
about the relationship between the stiffness of peripheral 
nerves and the severity of peripheral neuropathy and its 
underlying condition, although the results of some studies 
suggest that such a link might exist. These two issues need 
to be addressed in large-scale studies, preferably longitu-
dinal ones.
While based on the reproducibility data, SWE seems 
to be superior to SE, we still need to identify the sources of 
heterogeneity in the peripheral nerve stiffness in healthy 
persons. This information, along with the results of pop-
ulation-based studies of healthy persons, should be used 
to identify the sets of reference values for each peripheral 
nerve that is considered important from a clinical per-
spective. Finally, potential confounding effect of harden-
ing artefacts, such as bones, on the stiffness of peripheral 
nerves needs to be verified, and some technological coun-
termeasures should be introduced if necessary.
If all of the above issues are addressed satisfactori-
ly, elastographic evaluation of peripheral nerve stiffness 
might become a reliable, easily accessible, and convenient 
diagnostic test performed routinely in patients with vari-
ous peripheral neuropathies.
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